Antihypertensive combination therapy
This page covers all Antihypertensive combination therapy drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.
Phase 3 pipeline (2)
- L50/H12.5/A5 · Merck Sharp & Dohme LLC · Cardiovascular
L50/H12.5/A5 is a fixed-dose combination of three antihypertensive agents that work synergistically to reduce blood pressure through multiple pathways. - traditional triple antihypertensive treatment · First Affiliated Hospital of Chengdu Medical College · Cardiovascular
Traditional triple antihypertensive treatment combines three different classes of blood pressure-lowering agents to reduce systemic vascular resistance and blood pressure through complementary mechanisms.